Between the nonthrombocytopenic and thrombocytopenic patients, we observed statistically significant differences in mean age (63.3 ± 12.8 years versus 66.8 ± 11.8 years, p = 0.032), mean admission CRP (16.2 ± 42.3 mg/L versus 28.8 ± 53.0 mg/L, p = 0.030), and peak CRP levels (66.0 ± 82.8 mg/L versus 117.6 ± 93.8 mg/L, p < 0.001), prior stroke (4.1% versus 15.1%, p = 0.001), the incidence of STEMI (83.5% versus 68.4%, p = 0.004), and NSTEMI (16.5% versus 34.6%, p = 0.004) (Figure 1) (Table 1). The gene discussed is CRP; the disease is Stroke.